Active ingredientBrotizolamCat. No. P-B125-001CAS 57801-81-7Family · Pharmaceutical analytical standards
Brotizolam
A hypnotic of the thienotriazolodiazepine family, a close relative of the benzodiazepines: patented in 1974 and in medical use from 1984, it has been approved in several European countries, Italy included, and in Japan for the short-term treatment of severe insomnia. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?It also has a curious veterinary career: as an injectable solution it is used to stimulate appetite in cattle, for example during convalescence or after a change of feed.
Go to the active ingredient →Active ingredientBrotizolamCat. No. P-B125-001CAS 57801-81-7
Pharmacopoeial impurityBrotizolam EP Impurity BCat. No. P-B125-002CAS 57801-97-5No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceBrotizolam CRSEDQM code Y0000468Family BrotizolamImpurityBrotizolam impurity B CRSEDQM code Y0000470Family BrotizolamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.